the finnrick files.
the third-party peptide tester treated as the gold standard of the market. graded by the same four pillars they grade vendors with, the score isn't what you'd expect..
$100 once unlocks all paid features: every paid brief, Ask, the journal, and future paid updates, for life.
"finnrick is treated like the gold standard of peptide testing. graded by the same four pillars they grade vendors with, the score lands at 2 on independence and 9 on market influence. the rest of the brief is what that gap means."
- →the paid programs sold to the same vendors being graded
- →the krause analytical volume share + accreditation language + the documented 15% retatrutide discrepancy
- →the corrections log: scores move up, never down, anonymous lab codes, no public key
- →the $85-125k 'gray-market whisperer' job posting in their own words
- →the cap table, the missing methodology page, what the receipts say versus the trust signals
- →the buyer's read: how to hold finnrick coverage going forward
one read, ~17 minutes, primary sources on every claim, the methodology behind the investigation, and the buyer's-read for what to do about it. $100 once covers this brief plus every future one.
an undisclosed vendor on the reptides list pulled me aside last week and said hey, you've got finnrick wrong. i went and checked. i was kinda shook with what i found. so i kept pulling. seven findings later, the piece you're reading.
- 01i graded the auditor by their own rubricintro
- 02pillar 1: independence (score 2/10)the paid layer
- 03pillar 2: transparency (score 4/10)the methodology gap
- 04pillar 3: sample integrity (score 5/10)the per-product spread
- 05pillar 4: market influence (score 9/10)treated as primary
- 06the 2 -> 9 gap is the briefwhat the spread means
- 07methodologyhow i did this
- 08the buyer's readif you're paying for peptides right now
- 09what would change my readthe receipts that would matter
- 10what reptides is doing about itthe changes downstream of this brief
one payment for every reptides editorial brief, every research tool, and every future paid release. yours forever.